Pamapimod (R-1503, Ro4402257) is a novel, selective inhibitor of p38 mitogen-activated protein kinase. It inhibits p38 and p38 enzymatic activity with IC50 values of 0.0140.002 and 0.48 0.04 microM, respectively with no activity against p38delta or p38gamma isoforms.
For research use only. We do not sell to patients.